Somewhat Positive Media Coverage Somewhat Unlikely to Impact Dentsply Sirona (XRAY) Stock Price

Press coverage about Dentsply Sirona (NASDAQ:XRAY) has trended somewhat positive on Friday, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Dentsply Sirona earned a media sentiment score of 0.10 on Accern’s scale. Accern also assigned media coverage about the medical instruments supplier an impact score of 46.6874911252918 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

These are some of the headlines that may have impacted Accern Sentiment Analysis’s scoring:

How to Become a New Pot Stock Millionaire

Shares of Dentsply Sirona stock traded down $0.37 on Friday, hitting $49.72. The company had a trading volume of 188,467 shares, compared to its average volume of 2,436,574. The company has a debt-to-equity ratio of 0.24, a current ratio of 2.10 and a quick ratio of 1.45. The stock has a market capitalization of $11,488.92, a PE ratio of 19.00, a price-to-earnings-growth ratio of 2.21 and a beta of 1.26. Dentsply Sirona has a 52 week low of $48.25 and a 52 week high of $68.98.

Dentsply Sirona (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, March 1st. The medical instruments supplier reported $0.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.81 by $0.01. The business had revenue of $1.09 billion during the quarter, compared to analysts’ expectations of $1.06 billion. Dentsply Sirona had a negative net margin of 39.39% and a positive return on equity of 8.35%. The business’s revenue was up 9.5% on a year-over-year basis. During the same period last year, the firm posted $0.67 earnings per share. analysts forecast that Dentsply Sirona will post 2.74 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 13th. Investors of record on Thursday, March 29th will be issued a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a yield of 0.70%. The ex-dividend date of this dividend is Wednesday, March 28th. Dentsply Sirona’s payout ratio is 13.16%.

Several analysts have recently issued reports on XRAY shares. Credit Suisse Group cut shares of Dentsply Sirona to a “hold” rating and set a $73.00 price objective for the company. in a research note on Friday, January 5th. Zacks Investment Research cut shares of Dentsply Sirona from a “hold” rating to a “sell” rating in a research report on Monday, January 8th. JPMorgan Chase raised shares of Dentsply Sirona from a “neutral” rating to an “overweight” rating and set a $75.00 price objective for the company in a research report on Wednesday, December 13th. Deutsche Bank assumed coverage on shares of Dentsply Sirona in a research report on Friday, December 8th. They issued a “buy” rating and a $81.00 price objective for the company. Finally, HC Wainwright reissued a “hold” rating and issued a $68.00 price objective on shares of Dentsply Sirona in a research report on Thursday, December 7th. Three investment analysts have rated the stock with a sell rating, four have assigned a hold rating and nine have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $67.36.

In related news, Director Eric Brandt sold 6,409 shares of the firm’s stock in a transaction that occurred on Monday, January 8th. The shares were sold at an average price of $68.04, for a total transaction of $436,068.36. Following the completion of the sale, the director now directly owns 12,073 shares in the company, valued at $821,446.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 1.99% of the company’s stock.

TRADEMARK VIOLATION WARNING: This article was first posted by BBNS and is owned by of BBNS. If you are viewing this article on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The original version of this article can be viewed at https://baseballnewssource.com/2018/04/06/dentsply-sirona-xray-receiving-somewhat-positive-press-coverage-report-finds/2031479.html.

Dentsply Sirona Company Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Insider Buying and Selling by Quarter for Dentsply Sirona (NASDAQ:XRAY)

Receive News & Ratings for Dentsply Sirona Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply Sirona and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Almora Jr. and Baez Could Become Cubs new One-Two Tandem
Almora Jr. and Baez Could Become Cubs new One-Two Tandem
Red Sox Tie Record for Best Start After 17 Games
Red Sox Tie Record for Best Start After 17 Games
Bryce Harper Hits 406-Foot Home Run While Breaking His Bat
Bryce Harper Hits 406-Foot Home Run While Breaking His Bat
Rick Porcello’s Strong Start Gives Boost to Red Sox
Rick Porcello’s Strong Start Gives Boost to Red Sox
Two Bench Clearing Incidents Revive Red Sox-Yankees Rivalry
Two Bench Clearing Incidents Revive Red Sox-Yankees Rivalry
Xander Bogaerts Goes on Red Sox DL
Xander Bogaerts Goes on Red Sox DL


Leave a Reply

 
© 2006-2018 BBNS.